| A review of alprazolam use, misuse, and withdrawal N Ait-Daoud, AS Hamby, S Sharma, D Blevins Journal of addiction medicine 12 (1), 4-10, 2018 | 163 | 2018 |
| Women and addiction: an update N Ait-Daoud, D Blevins, S Khanna, S Sharma, CP Holstege, P Amin Medical Clinics 103 (4), 699-711, 2019 | 74 | 2019 |
| Women and addiction N Ait-Daoud, D Blevins, S Khanna, S Sharma, CP Holstege Psychiatric Clinics 40 (2), 285-297, 2017 | 47 | 2017 |
| Impulsiveness as a predictor of topiramate response for cocaine use disorder D Blevins, XQ Wang, S Sharma, N Ait‐Daoud The American journal on addictions 28 (2), 71-76, 2019 | 14 | 2019 |
| Well-being of health care professionals treating opioid use disorder during the COVID-19 pandemic: Results from a national survey D Blevins, BF Henry, M Sung, EJ Edelman, AC Black, M Dawes, ... Psychiatric Services 73 (4), 374-380, 2022 | 8 | 2022 |
| Clinical Implications of Substance Abuse in Young Adults. D Blevins, S Khanna Psychiatric Times 33 (1), 2016 | 7 | 2016 |
| A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysis D Blevins, C Seneviratne, XQ Wang, BA Johnson, N Ait-Daoud Drug and alcohol dependence 228, 109074, 2021 | 6 | 2021 |
| Impulsiveness as a moderator of amphetamine treatment response for cocaine use disorder among ADHD patients D Blevins, CJ Choi, M Pavlicova, D Martinez, JJ Mariani, J Grabowski, ... Drug and alcohol dependence 213, 108082, 2020 | 6 | 2020 |
| A review of alprazolam use, misuse, and withdrawal. J Addict Med. 2018; 12 (1): 4–10 N Ait-Daoud, AS Hamby, S Sharma, D Blevins Epub 2017/08/05. doi: 10.1097/adm. 0000000000000350, 0 | 6 | |
| State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements A Silwal, J Talbert, RM Bohler, J Kelsch, C Cook, D Blevins, M Gallivan, ... Drug and alcohol dependence reports 7, 100164, 2023 | 4 | 2023 |
| Adaptations to opioid use disorder care during the COVID-19 pandemic: a national survey of prescribers ML Sung, AC Black, D Blevins, BF Henry, K Cates-Wessel, MA Dawes, ... Journal of addiction medicine 16 (5), 505-513, 2022 | 4 | 2022 |
| An adaptive clinical trial design for cocaine use disorder: Extended-release amphetamine salts for early behavioral intervention non-responders D Blevins, KM Carpenter, D Martinez, JJ Mariani, FR Levin Contemporary clinical trials 98, 106187, 2020 | 4 | 2020 |
| Role for kappa-opioid system in stress-induced cocaine use uncovered with PET D Blevins, D Martinez Neuropsychopharmacology 45 (1), 233, 2020 | 2 | 2020 |
| A pilot study for video game therapy for substance cessation and recovery for nicotine dependence D Blevins, S Khanna, N Ait-Daoud AMERICAN JOURNAL ON ADDICTIONS 26 (3), 278-279, 2017 | 1 | 2017 |
| Effect of the Communities That HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trial LS Glasgow, C Douglas, JG Sprunger, ANC Campbell, R Chandler, ... Drug and Alcohol Dependence, 111286, 2024 | | 2024 |
| An Approach to Enhancing Medication Treatment for Opioid Use Disorder in the HEALing Communities Study JM Wai, D Blevins, T Hunt, L Gilbert, ANC Campbell, FR Levin, ... Psychiatric Services, appi. ps. 20230159, 2024 | | 2024 |
| Impact of the Communities That HEAL Intervention on Buprenorphine-Waivered Practitioners and Buprenorphine Prescribing: A Prespecified Secondary Analysis of the HCS Randomized … TJ Stopka, DC Babineau, EB Gibson, CE Knott, DM Cheng, J Villani, ... JAMA Network Open 7 (2), e240132-e240132, 2024 | | 2024 |
| New Federal Policy Change Intended to Expand Access to Buprenorphine of Opioid Use Disorder May be Limited By State Regulations C Thomas, R Bohler, A Silwal, J Talbert, L Fanucchi, T Hunt, S Hatcher, ... 2022 Annual Research Meeting, 2022 | | 2022 |
| Wellness of opioid use disorder healthcare professionals during the COVID-19 pandemic: Results from a national survey D Blevins, BF Henry, M Sung, EJ Edelman, AC Black, M Dawes, ... Psychiatric services (Washington, DC) 73 (4), 374, 2022 | | 2022 |
| PRESCRIBER AND PRACTICE CHARACTERISTICS ASSOCIATED WITH SUPPORT FOR OFFICE-BASED METHADONE: FINDINGS FROM A NATIONAL SURVEY M Sung, AC Black, D Blevins, BF Henry, K Cates-Wessel, MA Dawes, ... Journal of General Internal Medicine, S312-S312, 2022 | | 2022 |
